Expedient access to optically active fluorinated 2,4-trans-imidazolidines was successfully developed via Cu(I)-catalyzed exo'-selective 1,3-DC of azomethine ylides with fluorinated imines.
No takes yet. Share an insight, caveat, or question.
Li et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: